Keros Therapeutics (KROS) Net Margin (2019 - 2025)
Keros Therapeutics (KROS) posted Net Margin of 12479.26% for Q4 2025, down 24111.13% on a QoQ basis from 51.54% in Q3 2025, and down 1096624.0% year-over-year from N/an in Q4 2024.
Keros Therapeutics (KROS) Net Margin (2019 - 2025) Analysis & Trends
Keros Therapeutics' Net Margin history runs 6 years deep, the most recent figure standing at 12479.26% for Q4 2025.
- Quarterly Net Margin fell 1096624.0% year-over-year to 12479.26% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 35.7% (up 536884.0% YoY) and the FY2025 annual result came in at 35.68%, up 531323.0% from the prior year.
- Net Margin was 12479.26% for Q4 2025 at Keros Therapeutics, down from 51.54% in the prior quarter.
- Across five years, Net Margin topped out at 70.27% in Q1 2025 and bottomed at 493000.0% in Q3 2023.
- A 5-year average of 51389.39% and a median of 6996.14% in 2024 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2024 — Net Margin soared 47935155 bps — and 2025, when it sank 1096624 bps.
- Keros Therapeutics' Net Margin stood at 38.77% in 2021, then tumbled by 247 bps to 134.37% in 2022, then slumped by 20844 bps to 28141.96% in 2023, then jumped by 95 bps to 1513.02% in 2024, then tumbled by 725 bps to 12479.26% in 2025.
- Business Quant data shows KROS's Net Margin at 12479.26% in Q4 2025, 51.54% in Q3 2025, and 168.96% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 15.02% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 28.20% |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Keros Therapeutics | 374.82 Mn | 87.42 Mn | - | -12,479.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12,479.26% |
| Sep 30, 2025 | -51.54% |
| Jun 30, 2025 | -168.96% |
| Mar 31, 2025 | 70.27% |
| Dec 31, 2024 | -1,513.02% |
| Sep 30, 2024 | -13,648.45% |
| Mar 31, 2024 | -51,944.58% |
| Dec 31, 2023 | -28,141.96% |
| Sep 30, 2023 | -493,000.00% |
| Mar 31, 2022 | -134.37% |
| Dec 31, 2021 | -38.77% |
| Jun 30, 2021 | -15,622.00% |
| Dec 31, 2019 | -128.04% |
| Sep 30, 2019 | -159.96% |
| Jun 30, 2019 | -132.12% |
| Mar 31, 2019 | -145.32% |